Though the everolimus treatment with a simultaneous OTUD5 knockdown seems to be an ideal strategy, there is currently no specific inhibitor for OTUD5, and future discoveries of OTUD5 inhibitors may lead to some more effective bladder cancer treatments. Here, OTUD5 is linked to urinary bladder carcinoma.